Yet, it seems evident that the promising inhibitory effects of DNA demethylating agents against MLL‐rearranged ALL cells in vitro, were not indicative for similarly promising results in in vivo mouse models. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.